Molecular testing for cytologically suspicious and malignant (Bethesda V and VI) thyroid nodules to optimize the extent of surgical intervention: a retrospective chart review

BACKGROUND: Molecular testing has been used for cytologically indeterminate thyroid nodules (Bethesda III and IV), where the risk of malignancy is 10–40%. However, to date, the role of molecular testing in cytologically suspicious or positive for malignancy (Bethesda V and VI) thyroid nodules has be...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Otolaryngol Head Neck Surg
Main Authors: Hier, Jessica, Avior, Galit, Pusztaszeri, Marc, Krasner, Joshua R., Alyouha, Noura, Forest, Veronique-Isabelle, Hier, Michael P., Mlynarek, Alex, Richardson, Keith, Sadeghi, Nader, Tamilia, Michael, Payne, Richard J.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8082804/
https://ncbi.nlm.nih.gov/pubmed/33910629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40463-021-00500-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados